Clinical Trial Update: Combination Therapy With Carfilzomib for the Antibody-Mediated Rejection Diagnosis in Lung Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating combination therapy with carfilzomib for antibody-mediated rejection in lung transplantation completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Transplant Rejection

Drugs mentioned

• Carfilzomib (carfilzomib)

Snippet

Sponsor: John F. McDyer, MD | Conditions: Lung Transplant Rejection | Phase 2 | Status: COMPLETED | Results posted: 2022-04-25